BACK TO INDEX

Publications of C. Lubetzki
Articles in journal or book chapters
  1. C. Papeix, C. Lubetzki, and O. Lyon-Caen. [Current treatment for multiple sclerosis.]. Presse Med, 2010. Note: Journal article1983). [WWW]


  2. R. Schoemans, M. S. Aigrot, C. Wu, R. Maree, P. Hong, S. Belachew, C. Josse, C. Lubetzki, and V. Bours. Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. J Inherit Metab Dis, 2010. Note: Journal article. [WWW]


  3. G. Comi, V. Martinelli, M. Rodegher, L. Moiola, O. Bajenaru, A. Carra, I. Elovaara, F. Fazekas, H. P. Hartung, J. Hillert, J. King, S. Komoly, C. Lubetzki, X. Montalban, K. M. Myhr, M. Ravnborg, P. Rieckmann, D. Wynn, C. Young, and M. Filippi. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet, 374(9700):1503-11, 2009. Note: PreCISe study groupClinical Trial, Phase IIIJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Adult, Analysis of Variance, Disease Progression, Double-Blind Method, Female, Humans, Immunosuppressive Agents/adverse effects/*therapeutic use, Injections, Subcutaneous, Kaplan-Meiers Estimate, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Relapsing-Remitting/diagnosis/*drug therapy, Peptides/adverse effects/*therapeutic use, Proportional Hazards Models, Recurrence/prevention & control, Syndrome, Treatment Outcome.


  4. C. Lubetzki. [Axonal problems in demyelinating pathologies: role of inflammation and demyelinization]. Rev Neurol (Paris), 165 Spec No 2:F109-13, 2009. Note: Journal ArticleReviewFrance. [WWW] Keyword(s): Axons/pathology, Demyelinating Diseases/*pathology, Humans, Inflammation/*pathology, Multiple Sclerosis/*physiopathology, Nerve Degeneration/*pathology, Oligodendroglia/pathology.


  5. C. Papeix and C. Lubetzki. [Monoclonal antibodies in multiple sclerosis.]. Med Sci (Paris), 25(12):1113-5, 2009. Note: English AbstractJournal ArticleFranceM/s. [WWW]


  6. G. Piaton, A. Williams, D. Seilhean, and C. Lubetzki. Remyelination in multiple sclerosis. Prog Brain Res, 175:453-64, 2009. Note: Wellcome Trust/United KingdomJournal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW]


  7. M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki. From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain, 131(Pt 7):1686-700, 2008. Note: Journal articlea journal of neurology. [WWW]


  8. C. Lubetzki. Demyelinating diseases. Editorial. Curr Opin Neurol, 21(3):227-8, 2008. Note: EditorialIntroductory Journal ArticleEngland. [WWW]


  9. C. Lubetzki. [Regenerative capacity in multiple sclerosis]. Bull Acad Natl Med, 192(3):495-504;, 2008. Note: English AbstractJournal ArticleNetherlands. [WWW]


  10. F. Sedel, A. Tourbah, B. Fontaine, C. Lubetzki, N. Baumann, J. M. Saudubray, and O. Lyon-Caen. Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis, 31(3):295-307, 2008. Note: Journal ArticleNetherlands. [WWW]


  11. C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, T. Moreau, C. Lubetzki, P. Vermersch, E. Roullet, L. Magy, M. Tardieu, S. Suissa, and C. Confavreux. Natural history of multiple sclerosis with childhood onset. N Engl J Med, 356(25):2603-13, 2007. Note: Adult Neurology Departments KIDMUS Study GroupComparative StudyJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, *Age of Onset, Child, Child, Preschool, Cohort Studies, Disease Progression, Female, Humans, Infant, Kaplan-Meiers Estimate, Male, *Multiple Sclerosis, Observation, Prognosis.


  12. B. Stankoff, M. Bottlaender, M. S. Aigrot, F. Dolle, Y. Wang, C. Lubetzki, and B. Zalc. Imaging demyelination and remyelination in the CNS: the promise of Positron Emission Tomography (PET). Neuron Glia Biology, 2:S27-S27, 2007. Note: Suppl. 1242FBTimes Cited:0Cited References Count:0. [WWW]


  13. B. Stankoff, M. Bottlaender, M. Aigrot, F. Dolle, Y. Wang, C. Lubetzki, and B. Zalc. Imaging demyelination and remyelination in the CNS: the promise of positron emission tomography. Multiple Sclerosis, 13:S23-S23, 2007. Note: Suppl. 2238BXTimes Cited:0Cited References Count:0. [WWW]


  14. B. Stankoff, S. Mrejen, A. Tourbah, B. Fontaine, O. Lyon-Caen, C. Lubetzki, and M. Rosenheim. Age at onset determines the occurrence of the progressive phase of multiple sclerosis. Neurology, 68(10):779-781, 2007. [WWW]


  15. Y. Wang, C. W. Wu, R. Gould, D. Feinstein, Y. Feng, B. Stankoff, C. Lubetzki, and B. Zalc. In vivo imaging of myelin pathology in MS. Mult Scler, 13(2):293-293, 2007. [WWW]


  16. A. Williams, G. Piaton, M. S. Aigrot, A. Belhadi, M. Theaudin, F. Petermann, J. L. Thomas, B. Zalc, and C. Lubetzki. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain, 130(Pt 10):2554-65, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEnglanda journal of neurology. [WWW]


  17. A. Williams, G. Piaton, A. Belhadi, A. Kerever, M. S. Aigrot, I. Moutkine, C. Sarkis, P. Ravassard, B. Zalc, and C. Lubetzki. Sernaphorin 3A and 3F: key players in myelin repair in Multiple Sclerosis?. Neuron Glia Biology, 2:S107-S108, 2007. Note: Suppl. 1242FBTimes Cited:0Cited References Count:0. [WWW]


  18. A. Williams, G. Piaton, and C. Lubetzki. Astrocytes-Friends or foes in multiple sclerosis?. Glia, 55(13):1300-12, 2007. Note: Journal ArticleUnited States. [WWW]


  19. I. Coman, M. S. Aigrot, D. Seilhean, R. Reynolds, J. A. Girault, B. Zalc, and C. Lubetzki. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain, 129(Pt 12):3186-95, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEnglanda journal of neurology. [WWW]


  20. I. Coman, M. Aigrot, D. Seilhean, R. Reynolds, J. Girault, B. Zalc, and C. Lubetzki. Nodal, paranodal and juxtaparanodalaxonal proteins during demyelination and remyelination in multiple sclerosis. Mult Scler, 12:S139-S139, 2006. Note: Suppl. 1. [WWW]


  21. E. Le Page, E. Leray, B. Brochet, M. Clanet, P. Clavelou, C. Confavreux, M. Debouverie, C. Lebrun, C. Lubetzki, M. Madigand, J. Pelletier, E. Roullet, L. Rumbach, D. Brassat, and G. Edan. Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: final report. Mult Scler, 12:S211-S211, 2006. Note: Suppl. 1. [WWW]


  22. C. Lubetzki. [Therapeutic perspectives in multiple sclerosis]. Rev Prat, 56(12):1347-52, 2006. Note: English AbstractJournal ArticleReviewFrance. [WWW] Keyword(s): Adjuvants, Immunologic/therapeutic use, Antibodies, Monoclonal/therapeutic use, Humans, Multiple Sclerosis/*therapy, Myelin Sheath/drug effects/physiology, Stem Cell Transplantation.


  23. C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, T. Moreau, C. Lubetzki, P. Vermersch, E. Roullet, L. Magy, M. Tardieu, S. Suissa, and C. Confavreux. Childhood onset multiple sclerosis (the KIDMUS study): course and prognosis as compared to adult onset multiple sclerosis. Mult Scler, 12:S130-S131, 2006. Note: Suppl. 1. [WWW]


  24. F. Sedel, K. Friderici, K. Nummy, C. Caillaud, A. Chabli, A. Durr, C. Lubetzki, and Y. Agid. Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency. Arch Neurol, 63(1):129-31, 2006. Note: Case ReportsJournal ArticleUnited States. [WWW] Keyword(s): Adolescent, Humans, Male, Mutation/genetics, Tourette Syndrome/enzymology/genetics/*urine, beta-Mannosidase/*deficiency/urine.


  25. B. Stankoff, I. Arnulf, F. Viala, S. T. du Montcel, R. Assouad, L. Mallet, M. Tiberge, C. Papeix, B. Fontaine, A. Tourbah, O. L. Caen, C. Lubetzki, and M. Clanet. Disorders of excessive daytime sleepiness in MS patients with abnormal fatigue. Mult Scler, 12:S152-S152, 2006. Note: Suppl. 1. [WWW]


  26. B. Stankoff, Y. Wang, M. Bottlaender, M. S. Aigrot, F. Dolle, C. Wu, D. Feinstein, G. F. Huang, F. Semah, C. A. Mathis, W. Klunk, R. M. Gould, C. Lubetzki, and B. Zalc. Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A, 103(24):9304-9, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Anisoles/chemistry/metabolism, Biological Markers/metabolism, Carbon Radioisotopes/metabolism, Central Nervous System/*anatomy & histology, Encephalomyelitis, Autoimmune, Experimental/metabolism/pathology, Fluorescent Dyes/chemistry/metabolism, Humans, Mice, Mice, Inbred C57BL, Molecular Structure, Multiple Sclerosis/diagnosis/pathology, *Myelin Sheath/metabolism/pathology, Papio anubis, *Positron-Emission Tomography, Rats, Rats, Wistar, Stilbenes/chemistry/metabolism.


  27. A. Williams, G. Piaton, A. Belhadi, M. Aigrot, M. Theaudin, B. Zalc, and C. Lubetzki. Semaphorin 3A and 3F expression in multiple sclerosis and animal models of MS - Control of oligodendrocyte migration and axon remyelination. Mult Scler, 12:S10-S10, 2006. Note: Suppl. 1. [WWW]


  28. C. Wu, D. Tian, Y. Feng, P. Polak, J. Wei, A. Sharp, B. Stankoff, C. Lubetzki, B. Zalc, E. J. Mufson, R. M. Gould, D. L. Feinstein, and Y. Wang. A novel fluorescent probe that is brain permeable and selectively binds to myelin. J Histochem Cytochem, 54(9):997-1004, 2006. Note: Ns054109/ns/nindsJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the Histochemistry Society. [WWW] Keyword(s): Aniline Compounds/pharmacokinetics, Animals, Blood-Brain Barrier/metabolism, Brain/*metabolism, Cuprizone, Demyelinating Diseases/metabolism, Female, *Fluorescent Dyes/pharmacokinetics, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Myelin Sheath/*metabolism, Permeability, Stilbenes/pharmacokinetics.


  29. I. Coman, G. Barbin, P. Charles, B. Zalc, and C. Lubetzki. Axonal signals in central nervous system myelination, demyelination and remyelination. J Neurol Sci, 233(1-2):67-71, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewNetherlands. [WWW] Keyword(s): Animals, Axons/*pathology, Central Nervous System/metabolism/*pathology, Demyelinating Diseases/*pathology, Humans, Models, Biological, Myelin Sheath/*physiology, Neural Cell Adhesion Molecule L1/metabolism, Neural Inhibition, Sialic Acids/metabolism, *Signal Transduction.


  30. C. Jaillard, S. Harrison, B. Stankoff, M. S. Aigrot, A. R. Calver, G. Duddy, F. S. Walsh, M. N. Pangalos, N. Arimura, K. Kaibuchi, B. Zalc, and C. Lubetzki. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci, 25(6):1459-69, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesthe official journal of the Society for Neuroscience. [WWW] Keyword(s): Amino Acid Sequence, Animals, Ankyrins/analysis, Brain/cytology/growth & development, Brain Chemistry, Cell Differentiation, Cell Lineage, Cell Shape/drug effects, Cell Surface Extensions/drug effects/*physiology, Cell Survival/drug effects, Cells, Cultured/drug effects/metabolism/ultrastructure, Crosses, Genetic, Female, GTP-Binding Protein alpha Subunit, Gi2, GTP-Binding Protein alpha Subunits, Gi-Go/physiology, Intracellular Signaling Peptides and Proteins, Kv1.1 Potassium Channel, Lysophospholipids/*pharmacology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Molecular Sequence Data, Nerve Tissue Proteins/deficiency/genetics/metabolism/*physiology, Oligodendroglia/drug effects/*metabolism/ultrastructure, Phosphorylation, Potassium Channels, Voltage-Gated/analysis, Protein Processing, Post-Translational, Protein-Serine-Threonine Kinases/metabolism/physiology, Proto-Oncogene Proteins/physiology, Proto-Oncogene Proteins c-akt, RNA, Messenger/analysis, RNA, Small Interfering/pharmacology, Rats, Rats, Wistar, Receptors, Lysosphingolipid/deficiency/genetics/*physiology, Signal Transduction/drug effects/physiology, Sphingosine/*analogs & derivatives/pharmacology.


  31. C. Lubetzki, A. Williams, and B. Stankoff. Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol, 18(3):237-44, 2005. Note: Journal ArticleReviewEngland. [WWW] Keyword(s): Animals, Disease Models, Animal, Humans, Immunologic Factors/*therapeutic use, Multiple Sclerosis/complications/*therapy, Myelin Sheath/drug effects/physiology, Nerve Regeneration/*drug effects, Neurodegenerative Diseases/complications/therapy, Neuroprotective Agents/*therapeutic use, Wound Healing.


  32. F. Sedel, A. Tourbah, N. Baumann, B. Fontaine, P. Aubourg, C. Lubetzki, and O. Lyon-Caen. [Adult onset hereditary leukoencephalopathies]. Rev Neurol (Paris), 161(10):916-31, 2005. Note: English AbstractJournal ArticleReviewFrance. [WWW] Keyword(s): Age of Onset, Brain Diseases/diagnosis/*genetics/*metabolism, Demyelinating Diseases/diagnosis/*genetics/*metabolism, Humans, Mutation.


  33. B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki, and M. Clanet. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology, 64(7):1139-43, 2005. Note: French Modafinil Study GroupJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Benzhydryl Compounds/*administration & dosage/adverse effects, Central Nervous System Stimulants/*administration & dosage/adverse effects, Double-Blind Method, Fatigue/*drug therapy/etiology/prevention & control, Female, Gastrointestinal Diseases/chemically induced, Humans, Male, Middle Aged, Multiple Sclerosis/*complications, Placebos, Sleep Initiation and Maintenance Disorders/chemically induced, Treatment Outcome.


  34. G. Barbin, M. S. Aigrot, P. Charles, A. Foucher, M. Grumet, M. Schachner, B. Zalc, and C. Lubetzki. Axonal cell-adhesion molecule L1 in CNS myelination. Neuron Glia Biol, 1(1):65-72, 2004. Note: Journal ArticleEngland. [WWW]


  35. G. Barbin, M. S. Aigrot, P. Charles, M. Schachner, M. Grumet, B. Zalc, and C. Lubetzki. Axonal cell adhesion molecule L1 and central nervoyus system myelination. Neuron/Glia Biology, (1):65-72, 2004.


  36. A. Kreisler, B. Stankoff, M. J. Ribeiro, Y. Agid, C. Lubetzki, and B. Fontaine. Unexpected aggravation of Parkinson's disease by a mesencephalic multiple sclerosis lesion. J Neurol, 251(12):1526-7, 2004. Note: Case ReportsLetterGermany. [WWW] Keyword(s): Adult, Female, Humans, *Magnetic Resonance Imaging, Mesencephalon/*pathology, Multiple Sclerosis/*complications/*diagnosis, Parkinson Disease/*complications/*physiopathology, Severity of Illness Index.


  37. Y. Mikaeloff, S. Suissa, L. Vallee, C. Lubetzki, G. Ponsot, C. Confavreux, and M. Tardieu. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr, 144(2):246-52, 2004. Note: KIDMUS Study GroupJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Acute Disease, Adolescent, Age of Onset, Central Nervous System Diseases/*complications, Child, Child, Preschool, Cognition Disorders/complications, Cohort Studies, Demyelinating Diseases/*complications, Disability Evaluation, Encephalomyelitis, Acute Disseminated/diagnosis/etiology, Female, Humans, Infant, Magnetic Resonance Imaging, Male, Multiple Sclerosis/diagnosis/etiology, Myelitis, Transverse/complications, Optic Neuritis/complications/diagnosis, Prognosis, Recurrence, Survival Analysis.


  38. C. Lubetzki. [The remyelination phenomenon in multiple sclerosis]. Bull Acad Natl Med, 187(4):699-707;, 2003. Note: English AbstractJournal ArticleReviewNetherlands. [WWW] Keyword(s): Animals, Astrocytes/physiology, Axons/ultrastructure, Disease Models, Animal, Growth Substances/physiology/therapeutic use, Humans, Macrophages/physiology, Multiple Sclerosis/drug therapy/*physiopathology, Myelin Sheath/*physiology, Oligodendroglia/physiology.


  39. C. Moreau-Fauvarque, A. Kumanogoh, E. Camand, C. Jaillard, G. Barbin, I. Boquet, C. Love, E. Y. Jones, H. Kikutani, C. Lubetzki, I. Dusart, and A. Chedotal. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci, 23(27):9229-39, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesthe official journal of the Society for Neuroscience. [WWW] Keyword(s): Animals, *Antigens, CD, Axons/drug effects/*physiology, Biological Markers/analysis, Cells, Cultured, Central Nervous System/*metabolism/pathology, Membrane Glycoproteins/genetics/*metabolism/pharmacology, Mice, Mice, Inbred Strains, Mice, Transgenic, Myelin Sheath/metabolism, Oligodendroglia/*metabolism/pathology, RNA, Messenger/metabolism, *Semaphorins, Spinal Cord Injuries/*metabolism/pathology, Up-Regulation.


  40. E. Waubant, S. Tezenas du Montcel, C. Jedynak, M. Obadia, H. Hosseini, P. Damier, C. Lubetzki, Y. Agid, and J. D. Degos. Multiple sclerosis tremor and the Stewart-Holmes manoeuvre. Mov Disord, 18(8):948-52, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the Movement Disorder Society. [WWW] Keyword(s): Adult, Cerebellar Diseases/*complications/*diagnosis/physiopathology, Diagnosis, Differential, Female, Humans, Male, Multiple Sclerosis/*complications/diagnosis/physiopathology, Posture/physiology, Severity of Illness Index, Tremor/diagnosis/*etiology/physiopathology.



BACK TO INDEX



Disclaimer:

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.



Last modified: Thu May 6 18:23:13 2010
Author: schwartz.

This document was translated from BibTEX by bibtex2html